Inspire Investing’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Buy
24,400
+20,631
+547% +$1.44M 0.09% 279
2025
Q4
$250K Buy
3,769
+630
+20% +$40.7K 0.02% 825
2025
Q3
$211K Buy
3,139
+180
+6% +$14.2K 0.02% 835
2025
Q2
$258K Buy
+2,959
New +$232K 0.03% 797
2022
Q3
Sell
-4,253
Closed -$317K 782
2022
Q2
$317K Buy
4,253
+1,257
+42% +$115K 0.04% 246
2022
Q1
$383K Sell
2,996
-4,552
-60% -$498K 0.04% 264
2021
Q4
$1.01M Buy
7,548
+672
+10% +$96.6K 0.12% 164
2021
Q3
$940K Buy
+6,876
New +$867K 0.12% 188
2021
Q1
Sell
-3,920
Closed -$362K 638
2020
Q4
$362K Buy
+3,920
New +$350K 0.08% 347
2020
Q2
Sell
-132
Closed -$9K 567
2020
Q1
$9K Buy
+132
New +$8.21K ﹤0.01% 706

Other funds holding DXCM

Inspire Investing's DXCM Position: Q1 2026 in Review

Inspire Investing increased its DexCom (DXCM) stake by 547% in Q1 2026, buying an estimated $1.44M and bringing the position to 24,400 shares worth $1.53M. The position accounts for 0.09% of the portfolio, ranked #279.

Inspire Investing first reported a position in DXCM in Q1 2020 and has held it in 10 quarters since. 958 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Inspire Investing held 24,400 shares of DexCom worth $1.53M as of Q1 2026.
  • Inspire Investing bought 20,631 DexCom shares in Q1 2026, an estimated $1.44M.
  • DexCom made up 0.09% of Inspire Investing's portfolio in Q1 2026, its #279 holding.
  • Inspire Investing first reported a position in DexCom in Q1 2020 and has held it in 10 quarters since.
  • 958 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.